Прати
Jeffrey Michael Rogers
Jeffrey Michael Rogers
SDSU/UCSD Joint Doctoral Program in Clinical Psychology
Верификована је имејл адреса на nih.gov
Наслов
Навело
Навело
Година
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
KE Smith, JM Rogers, D Schriefer, O Grundmann
Drug and Alcohol Dependence 226, 108879, 2021
622021
Kratom use as more than a “self-treatment”
KE Smith, KE Dunn, JM Rogers, O Grundmann, CR McCurdy, ...
The American Journal of Drug and Alcohol Abuse, 1-11, 2022
422022
Social, psychological, and substance use characteristics of US adults who use kratom: Initial findings from an online, crowdsourced study.
KE Smith, KE Dunn, O Grundmann, A Garcia-Romeu, JM Rogers, ...
Experimental and Clinical Psychopharmacology, 2021
422021
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
K Smith, J Rogers, K Dunn, O Grundmann, C McCurdy, D Schriefer, ...
The Pharmacology of Kratom and Its Alkaloids, 2022
392022
Assessment of Kratom Use Disorder and Withdrawal Among an Online Convenience Sample of US Adults.
KE Smith, KE Dunn, JM Rogers, A Garcia-Romeu, JC Strickland, ...
Journal of Addiction Medicine, 2022
372022
When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use
KE Smith, JM Rogers, JC Strickland, DH Epstein
The American Journal of Drug and Alcohol Abuse, 1-12, 2021
362021
Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults
JM Rogers, J Gills, M Gray
Journal of the International Society of Sports Nutrition 17 (1), 1-8, 2020
302020
Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample
J Rogers, K Smith, J Strickland, D Epstein
Frontiers in Pharmacology 12, 2021
252021
Need for clarity and context in case reports on kratom use, assessment, and intervention
KE Smith, KE Dunn, DH Epstein, JD Feldman, A Garcia-Romeu, ...
Substance Abuse 43 (1), 1221-1224, 2022
142022
How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media data
O Grundmann, CA Veltri, D Morcos, D Knightes III, KE Smith, JM Rogers
Substance Abuse 43 (1), 865-877, 2022
132022
Kava (Piper methysticum) in the United States: the quiet rise of a substance with often subtle effects
S Pont-Fernandez, M Kheyfets, JM Rogers, KE Smith, DH Epstein
The American Journal of Drug and Alcohol Abuse, 1-12, 2022
132022
Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample
KE Smith, JM Rogers, JC Strickland
Journal of psychoactive drugs, 1-11, 2021
132021
Novel methods for the remote investigation of emerging substances: Application to kratom.
KE Smith, JD Feldman, KE Dunn, CR McCurdy, O Grundmann, ...
Experimental and Clinical Psychopharmacology, 2023
112023
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study
KE Smith, JM Rogers, A Sharma, CR McCurdy, ST Weiss, KE Dunn, ...
Journal of Addiction Medicine, 10.1097, 2023
102023
Kratom’s Emergence and Persistence Within the US Polydrug Epidemic
KE Smith, JM Rogers, JD Feldman
Current Addiction Reports, 1-10, 2023
102023
The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
JM Rogers, JE Iudicello, MCG Marcondes, EE Morgan, M Cherner, ...
Viruses 15 (3), 674, 2023
92023
For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic
JM Rogers, KE Smith, D Schriefer, DH Epstein
Substance Abuse: Research and Treatment 16, 11782218221123977, 2022
72022
Exploring the Relationship Between Substance Use and Allostatic Load in a Treatment/Research Cohort and in a US Probability Sample (NHANES 2009–2016)
JM Rogers, DH Epstein, K Phillips, JC Strickland, KL Preston
Frontiers in Psychiatry, 1285, 2021
72021
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency
JM Rogers, ST Weiss, DH Epstein, O Grundmann, K Hill, KE Smith
Drug and Alcohol Dependence 260, 111329, 2024
62024
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys
JM Rogers, K Colvin, DH Epstein, O Grundmann, CR McCurdy, KE Smith
Frontiers in Pharmacology 15, 1412397, 2024
52024
Систем тренутно не може да изврши ову радњу. Пробајте поново касније.
Чланци 1–20